Press Releases

Myomo® Application for Medicare Codes Receives Favorable Preliminary Decision

By Alex Fusco | May 14, 2018 | 0 Comments

CAMBRIDGE, Mass., May 14, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo,” or the “Company”), a wearable medical robotics company, announces that the Centers for Medicare & Medicaid Services (“CMS”) has published a favorable preliminary decision regarding the Company’s application for Healthcare Common Procedure Coding System (HCPCS) “L” codes. Myomo had filed its application in December…

Myomo Reports First Quarter 2018 Results

By Alex Fusco | May 9, 2018 | 0 Comments

CAMBRIDGE, Mass., May 9, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today reports its financial results for the first quarter ended March 31, 2018. Read more.  

Myomo to Report First Quarter 2018 Results on May 9, 2018

By Alex Fusco | May 3, 2018 | 0 Comments

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will release its financial results for the first quarter 2018 on Wednesday, May 9, 2018, after the US markets close. Read more.

Myomo Announces Free Screening Days in Over 20 Cities Nationwide

By Alex Fusco | May 2, 2018 | 0 Comments

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, announces a nationwide program of free screening days to be held in collaboration with its Centers of Excellence, other orthotics and prosthetics practices and its rehabilitation therapy partners. Read more.

UPDATE – Myomo Reports Fourth Quarter and Year End 2017 Results

By Alex Fusco | March 16, 2018 | 0 Comments

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it is updating its previous release that was made on March 7, 2018 to incorporate certain disclosures that are required under the NYSE AMERICAN Company Guide Sections 401(h) and 610(b). Included below are these additional…

Myomo Welcomes 13 New Center of Excellence Locations

By Alex Fusco | March 12, 2018 | 0 Comments

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the addition of three new orthotics and prosthetics (O&P) practices and 13 new locations to its MyoPro Center of Excellence (CoE) program, which recognizes top O&P practices that support the MyoPro line of powered orthoses. The…

Myomo Announces Participation at Upcoming Investor and Partnering Conferences

By Alex Fusco | March 9, 2018 | 0 Comments

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that Chairman and Chief Executive Officer Paul R. Gudonis will be participating at two upcoming investor, partnering and collaboration conferences. Read more.

Myomo, Inc. Issues March 2018 Shareholder Letter

By Alex Fusco | March 8, 2018 | 0 Comments

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today issued a letter to shareholders to give an update on fourth quarter 2017 and ongoing MyoPro® commercial activities. Read more.

Myomo Reports Fourth Quarter and Year End 2017 Results

By Alex Fusco | March 7, 2018 | 0 Comments

CAMBRIDGE, Mass., March 7, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the fourth quarter and year end December 31, 2017. Read more.

Myomo to Present at the 30th Annual ROTH Conference

By Alex Fusco | March 5, 2018 | 0 Comments

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will be presenting at the 30th Annual ROTH Conference in Dana Point, CA on Monday, March 12th at 9:00 AM PT, Blue – Salon 2. Chairman and Chief Executive Officer Paul R. Gudonis will be…